Myriad Genetics, Inc.

Salt Lake City, UT 84108

Market Performance

NASDAQ: MYGN
Market Cap $2.35 Billion
52 Week High $37.30
52 Week Low $15.15

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $185K
First Award Date 07/01/00
Most Recent Award Date 07/01/00

Key Personnel

Last Name Name Awards Contact
Morham Scott G Morham 1

1 Award Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/00 - 06/30/01

The genes responsible for the majority of familial colorectal cancer cases have not yet been identified. Myriad Genetics, Inc. has at its disposal many extended, high risk colon cancer pedigrees that are not linked to any of the identified colon cancer predisposition syndromes, familial adenomatous polyposis (FAP) or hereditary nonpolyposis colo...